1-20 of 74
Alice Mims
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

A multicenter real-world study on response and survival in older patients with acute myeloid leukemia treated with intensive chemotherapy versus VEN/HMA by 2022 and 2024 ELN risk stratifications: An analysis from the MARROW consortium

Free
Nilesh Kapoor, Deedra Nicolet, Krzysztof Mrózek, Najla Al Ali, Alex Ambinder, Julia Anderson, Lauren Banaszak, Bianca Barredo, Onyee Chan, Charles Foucar, Andres Gomez-De Leon, Jesus Gonzalez-Lugo, Nicole Lux, Christine McMahon, Brittany Ragon, Kieran Sahasrabudhe, Joshua Zeidner, Alice Mims, Ann-Kathrin Eisfeld, Yazan Madanat
Journal: Blood
Blood (2025) 146 (Supplement 1): 5157.
https://doi.org/10.1182/blood-2025-5157
Published: 2025
Journal Articles

Phase 1b/2 study of axatilimab in combination with azacitidine in advanced Phase MPN, MDS/ MPN overlap and high-risk CMML

Free
Uma Borate, Shivani Handa, Ying Huang, Kaitlyn Dvorak-Kornaus, Nicole Grieselhuber, Alice Mims
Journal: Blood
Blood (2025) 146 (Supplement 1): 5607.
https://doi.org/10.1182/blood-2025-5607
Published: 2025
Journal Articles

Exploiting RAS pathway addiction as a therapeutic vulnerability in myeloid sarcoma

Free
Audrey Lasry, Bettina Nadorp, Sanam Loghavi, Ravi Patel, Hager Mansour, Ben Kelly, Christopher Walker, Jill Buss, Isaiah Boateng, Wafa Al-Santli, Zoe Ciantra, Rebecca Austin, Adrienne Heyrosa, Helee Desai, Andrea Laganson, Hasan Abaza, Linda Procell, Tejas Patel, Benjamin Kaffenberger, Saranga Wijeratne, Maria Guillamot, Maria Velegraki, Luis Chiriboga, Zihai Li, Lynne Abruzzo, Daniel Pollyea, Christine McMahon, Arwa Shana'Ah, John Byrd, Alan Shih, Ross Levine, Eirini Papapetrou, Aristotelis Tsirigos, Elaine Mardis, Alice Mims, Iannis Aifantis, Ann-Kathrin Eisfeld
Journal: Blood
Blood (2025) 146 (Supplement 1): 220.
https://doi.org/10.1182/blood-2025-220
Published: 2025
Journal Articles

A phase 1/1b open-label, dose escalation, first-in-human study to evaluate the safety, tolerability, pharmacokinetics, and preliminary anti-leukemic activity of the orally available clk inhibitor, BH-30236, in adults with R/R AML or HR-MDS

Free
Eytan Stein, Alice Mims, Zhuoer Xie, Gabriel Mannis, Justin Watts, Farhad Ravandi, Gary Schiller, Brian Ball, Hongtao Liu, Jessica Altman, Eunice Wang, J. Jean Cui, Jihao Zhou, Zachary Zimmerman, Stephen Strickland
Journal: Blood
Blood (2025) 146 (Supplement 1): 1655.
https://doi.org/10.1182/blood-2025-1655
Published: 2025
Journal Articles

Bleximenib or placebo in combination with standard induction and consolidation therapy followed by maintenance for the treatment of patients with newly diagnosed KMT2A-rearranged or NPM1-mutant Acute Myeloid Leukemia eligible for intensive chemotherapy: A double-blind Phase 3 study (HOVON 181 AML / AMLSG 37-25)

Free
Marc Raaijmakers, Hartmut Döhner, Dimitri Breems, John Byrd, Konstanze Döhner, Jordi Esteve, Bjørn Gjertsen, Patrycja Gradowska, Gerwin A. Huls, Ain Kaare, Heeje Kim, Hitoshi Kiyoi, Mika Kontro, Janusz Krawczyk, Vladimir Lazarevic, Andrea Lenartova, Alice Mims, Jeannine Refos, Christoph Röllig, Anika Schrade, Karolina Sikorska, Alexandre Theocharides, Peter Valk, Adriano Venditti, Jianxiang Wang, Andrew Wei, Agnieszka Wierzbowska, Andrius Zucenka, Lucille Ferrante, Christina Drenberg Guttke, Angélique Langlois, Christina Loefgren, Kathryn Packman, Prathap Nagaraja Shastri, Natasha Schuier, Meena Thayu, Danielle Trancucci, Bob Lowenberg, Lars Bullinger
Journal: Blood
Blood (2025) 146 (Supplement 1): 1654.
https://doi.org/10.1182/blood-2025-1654
Published: 2025
Journal Articles

RAS mutations negate the favorable impact of NPM1 in older patients with newly diagnosed Acute Myeloid Leukemia treated with ven/HMA

Free
Fieke Hoff, Alexander Li, Ying Huang, Rina Welkie, Ronan Swords, Elie Traer, Eytan Stein, Tara Lin, Maria Baer, Vu Duong, William Blum, Martha Arellano, Wendy Stock, Olatoyosi Odenike, Joshua Zeidner, Rebecca Olin, Catherine Smith, Gary Schiller, Emily Curran, Shivani Handa, Nyla Heerema, Timothy Chen, Molly Martycz, Mona Stefanos, Sonja Marcus, Leonard Rosenberg, Brian Druker, Ross Levine, Ashley Yocum, Uma Borate, Alice Mims, John Byrd, Yazan Madanat
Journal: Blood
Blood (2025) 146 (Supplement 1): 995.
https://doi.org/10.1182/blood-2025-995
Published: 2025
Journal Articles

Updated response and safety analyses from a Phase 1 study of ivosidenib combined with intensive chemotherapy in patients with newly diagnosed (ND) Acute Myeloid Leukemia with isocitrate dehydrogenase (IDH)1 mutation

Free
Eytan Stein, Courtney DiNardo, Amir Fathi, Alice Mims, Keith Pratz, Michael Savona, Anthony Selwyn Stein, Richard Stone, Eric Winer, Christopher Seet, Hartmut Döhner, Dan Pollyea, James McCloskey, Olatoyosi Odenike, Bob Lowenberg, Gert J. Ossenkoppele, Mikhail Roshal, Sung Choe, Qian Meng, Stephanie Kapsalis, Prapti Patel, Hagop Kantarjian, Martin Tallman
Journal: Blood
Blood (2025) 146 (Supplement 1): 992.
https://doi.org/10.1182/blood-2025-992
Published: 2025
Journal Articles

Toxicity of reduced dose versus standard dose pegaspargase in adolescents and young adults with acute lymphoblastic leukemia

Free
Megan Fleming, Allyson Waller, Subodh Bhatta, Pooja Kumar, Tracelyn Freeman, Lexus Frazier, Nilmarie Ayala-Fontanez, Adithya Ghantae, Sharon Loo, Jasmine Kainth, Ying Huang, James Blachly, Bradley Blaser, Uma Borate, Ann-Kathrin Eisfeld, Nicole Grieselhuber, Shivani Handa, Jayanshu Jain, Karilyn Larkin, Meixiao Long, Alice Mims, Andrew Srisuwananukorn, Gregory Behbehani
Journal: Blood
Blood (2025) 146 (Supplement 1): 3344.
https://doi.org/10.1182/blood-2025-3344
Published: 2025
Journal Articles

Characteristics and clinical outcomes of patients (pts) with Acute Myeloid Leukemia (AML) with Mecom rearrangements: An analysis from the MARROW consortium

Free
Jesus Gonzalez-Lugo, Alex Ambinder, Deedra Nicolet, Krzysztof Mrózek, Maire Okoniewski, Yazan Madanat, Michael Walker, Charles Foucar, Christine McMahon, Michael Hochman, Brittany Ragon, Joshua Zeidner, Kieran Sahasrabudhe, Anna Bode, Bianca Barredo, Lauren Banaszak, Rami Komrokji, Alice Mims, Onyee Chan, Tara Lin, Ann-Kathrin Eisfeld
Journal: Blood
Blood (2025) 146 (Supplement 1): 294.
https://doi.org/10.1182/blood-2025-294
Published: 2025
Journal Articles

Defining the clinical characteristics and outcomes of adult patients (pts) with 11q23/KMT2A-rearranged Acute Myeloid Leukemia (AML): An analysis from the MARROW consortium

Free
Christine McMahon, Deedra Nicolet, Alice Mims, Charles Foucar, Yazan Madanat, Brittany Ragon, Kieran Sahasrabudhe, Onyee Chan, Joshua Zeidner, Michael Hochman, Daniel Pollyea, Krzysztof Mrózek, Michael Walker, Fnu Amritpal Singh, Tara Lin, Bianca Barredo, Lauren Banaszak, Jesus Gonzalez-Lugo, Alex Ambinder, Ann-Kathrin Eisfeld
Journal: Blood
Blood (2025) 146 (Supplement 1): 292.
https://doi.org/10.1182/blood-2025-292
Published: 2025
Journal Articles

Phase 1b safety run-in study followed by Phase 2 study of ficlatuzumab, azacitidine and venetoclax in untreated Acute Myeloid Leukemia patients aged ≥ 60 years old

Free
Emily Curran, Ying Huang, Shivani Handa, Ronan Swords, Eytan Stein, Maria Baer, Wendy Stock, Yazan Madanat, Rebecca Olin, William Blum, Gary Schiller, Tara Lin, Joshua Zeidner, Bradley Blaser, Molly Martycz, Leonard Rosenberg, Sonja Marcus, Timothy Chen, Mona Stefanos, Ashley Yocum, Ross Levine, Brian Druker, Uma Borate, Alice Mims, John Byrd
Journal: Blood
Blood (2025) 146 (Supplement 1): 3432.
https://doi.org/10.1182/blood-2025-3432
Published: 2025
Journal Articles

Preliminary Results of A phase 1 study of the safety and tolerability of the combination of revumenib (REV) with gilteritinib (GILT) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML)

Free
Uma Borate, Jayanshu Jain, Ying Huang, Kaitlyn Dvorak-Kornaus, Alexander Perl, Joshua Zeidner, Alice Mims
Journal: Blood
Blood (2025) 146 (Supplement 1): 3427.
https://doi.org/10.1182/blood-2025-3427
Published: 2025
Journal Articles

Evaluation of cytarabine consolidation dosing in older adult patients with Acute Myeloid Leukemia

Free
Pooja Kumar, Deedra Nicolet, Tracelyn Freeman, Lexus Frazier, Allyson Waller, Megan Fleming, Michael Walker, Gregory Behbehani, James Blachly, Uma Borate, Nicole Grieselhuber, Shivani Handa, Jayanshu Jain, Karilyn Larkin, Meixiao Long, Ann-Kathrin Eisfeld, Alice Mims
Journal: Blood
Blood (2025) 146 (Supplement 1): 3408.
https://doi.org/10.1182/blood-2025-3408
Published: 2025
Journal Articles

Results from paradigm - a phase 2 randomized multi-center study comparing azacitidine and venetoclax to conventional induction chemotherapy for newly diagnosed fit adults with acute myeloid leukemia

Free
Amir Fathi, Alexander Perl, Geoffrey Fell, Brian Jonas, Brittany Ragon, Alice Mims, Uma Borate, Gabriel Mannis, Karen Quillen, Max Stahl, Paul Koller, Andrew Artz, Monzr M. Al Malki, Guido Marcucci, Mary Linton Peters, Timothy Graubert, Peter Westervelt, Philip Amrein, Hanno Hock, Andrew Brunner, Gabriela Hobbs, Rupa Narayan, Michelle Lee, Brandon Aubrey, Alyssa Watson, Richard Hao, Shilton Dhaver, Michael Grunwald, Yi-Bin Chen, Andrew Matthews, Christopher Hourigan, Brent Wood, Donna Neuberg, Areej El-Jawahri, Ibrahim Aldoss
Journal: Blood
Blood (2025) 146 (Supplement 1): 6.
https://doi.org/10.1182/blood-2025-6
Published: 2025
Journal Articles

Comparative impact of tyrosine kinase inhibitor dose-reduction on ability to achieve treatment-free remission among TKI-intolerant patients with chronic myeloid leukemia

Free
Melanie Rebechi, Nidhi Sharma, Audrey Propp, Qiuhong Zhao, Michael Marcucci, Allyson Waller, Marvellous Olowookere, Alyssa Swank, Christian Hu, Alice Mims, Jennifer Vaughn
Journal: Blood
Blood (2025) 146 (Supplement 1): 2004.
https://doi.org/10.1182/blood-2025-2004
Published: 2025
Journal Articles

Management and outcomes of patients diagnosed with chronic myeloid leukemia in blast Phase: A multicenter analysis by the h jean khoury cure CML consortium

Free
Akriti Jain, Umar Iqbal, Colin Vale, Anthony Hunter, Wei Wei, Kinaya Smith, Shivani Handa, Allyson Waller, Alice Mims, Benjamin McCormick, Genevieve Crane, Ling Zhang, Asmita Shukla, Jay Yang, Amanda Dailey-Hansen, Srinivas Tantravahi, Suravi Raychaudhuri, Vivian Oehler, Jerald Radich, B. Douglas Smith, Nhi Nai, Charles Foucar, Onyee Chan, Javier Pinilla-Ibarz, Michael Deininger, Talha Badar, Sudipto Mukherjee, Kendra Sweet, Ehab Atallah, Zhuoer Xie
Journal: Blood
Blood (2025) 146 (Supplement 1): 904.
https://doi.org/10.1182/blood-2025-904
Published: 2025
Journal Articles

A phase 1 dose escalation and dose optimization study to evaluate the preliminary safety, tolerability, pharmacokinetic, pharmacodynamic, and clinical activity profile of AUTX703 in participants with relapsed/refractory acute myeloid leukemia and myelodysplastic syndromes

Free
Stephen Strickland, Eunice Wang, Brian Ball, Alice Mims, Joshua Zeidner, Xin Wang, Rory Shallis, Catherine Lai, Katharine Yen, David Millan, Joseph DeBartolo, James Neef, Laura Antipov, Erika Manyak, Rachael Kendrick, Guangbin Peng, Kimberly Straley, Caroline Almon, Carrie Brownstein, Courtney DiNardo
Journal: Blood
Blood (2025) 146 (Supplement 1): 6952.
https://doi.org/10.1182/blood-2025-6952
Published: 2025
Journal Articles

Revumenib in combination with intensive induction and consolidation for newly diagnosed patients with NPM1-mutated or KMT2A-rearranged Acute Myeloid Leukemia: Preliminary results from the Phase 1b etctn 10596 study

Free
Alice Mims, Lai Wei, Eric McLaughlin, Jayanshu Jain, Joshua Zeidner, Olatoyosi Odenike, Sangeetha Venugopal, James Blachly, Vu Duong, Anand Patel, Eric Eisenmann, Shelley Orwick, Daelynn Buelow, Gregory Behbehani, Richard Little, Steven Gore, Sharyn Baker
Journal: Blood
Blood (2025) 146 (Supplement 1): 5206.
https://doi.org/10.1182/blood-2025-5206
Published: 2025
Journal Articles

Clinical and molecular characteristics of Philadelphia chromosome positive B-cell precursor acute lymphoblastic leukemia with central nervous system relapse versus systemic relapse: Results from consortium on myeloid malignancies and neoplastic diseases (COMMAND)

Free
Rafael Madero-Marroquin, Ravi Kishore Narra, Alice Mims, Alexander Coltoff, Georgio Medawar, Brooke Hisrich, Rory Shallis, Cameron Hunter, Vamsi Kota, Tamer Othman, Brian Jonas, Shreya Desai, Guilherme Sacchi De Camargo Correia, Adam Duvall, Neil Palmisiano, Emily Curran, Zulfa Omer, Anjali Advani, Ehab Atallah, Mark Litzow, Anand Patel, Talha Badar
Journal: Blood
Blood (2025) 146 (Supplement 1): 3320.
https://doi.org/10.1182/blood-2025-3320
Published: 2025
Journal Articles

Inotuzumab ozogamicin then blinatumomab for older adults with newly diagnosed, ph-negative, CD22-positive, B-cell acute lymphoblastic leukemia: Extended follow-up of alliance for clinical trials in oncology A041703 cohort 1 reveals durable remission and survival

Free
Matthew Wieduwilt, Jun Yin, Oudom Kour, Rebecca Teske, Wendy Stock, Carolin Escherich, Jun J. Yang, Zhenhua Li, Ken Byrd, Kimberley Doucette, James Mangan, Scott Hall, Alice Mims, Katarzyna Jamieson, Shira Dinner, Ali Bseiso, Georgia Giordano, Caner Saygin, Geoffrey Uy, Mark Litzow, Richard Stone
Journal: Blood
Blood (2025) 146 (Supplement 1): 444.
https://doi.org/10.1182/blood-2025-444
Published: 2025